news
14 May 2021
Cancer patients are at risk of becoming malnourished, both as a consequence of their illness and its treatment. Malnutrition and related loss of weight and lean body mass negatively impact patient prognosis. For this reason, our aim is for medical nutrition to become an increasingly integral and relevant part of cancer care. At Danone Nutricia Research, we recognise that cancer patients have different nutritional needs at each stage of their illness. Our objective is to research and develop innovative medical nutrition that supports them along their journey.
The cancer journey
At Danone Nutricia Research, we aim to develop innovative medical nutrition that supports patients throughout their cancer journey, from diagnosis through to treatment and recovery, or into palliative care.
Learn more
Nutrition can improve outcomes in cancer care
At Danone Nutricia Research, we study specific nutrients and their potential roles in improving outcomes for cancer patients.
Learn more
A patient-focused innovation process
Management of cancer-related malnutrition and cachexia should be an integral part of cancer care.
Learn moreMore Articles
Our Key Expert
Marion Jourdan
Research program leader, Oncology
Danone Nutricia Research
“We believe medical nutrition should be an integral part of cancer treatment and care. The needs of cancer patients are at the core of every innovation and how we approach any new product development.”
View All People